Shaoxing Zhu

Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma

Dingwei Ye, Jiyan Liu, Aiping Zhou et al. · Cancer Science · 2020 · 116 citations · Full text

Life Sciences, Immunology, Oncology +17

Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial

Weijie Gu, Weiqing Han, Hong Luo et al. · The Lancet Oncology · 2022 · 66 citations

Medicine, Oncology, Urology +16

MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells

Wei Zhang, Yeqing Mao, Hua Wang et al. · Cancer Cell International · 2015 · 59 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma

Zhuo Chen, Xiao Liu, Zhengjie Zhu et al. · Frontiers in Genetics · 2022 · 58 citations · Full text

Medicine, Bioinformatics, Oncology +14

Nitric oxide synthase expression in human bladder cancer and its relation to angiogenesis

Zhen Lin, Shiping Chen, Chuanzhong Ye et al. · Urological Research · 2003 · 52 citations

Medicine, Oncology, Urology +12